Novo Nordisk Before Q4 Earnings: How Should Investors Play the Stock?

Novo Nordisk (NVO) is scheduled to report fourth-quarter 2024 results on Feb. 5, 2025, before the opening bell. The Zacks Consensus Estimate for quarterly revenues in the to-be-reported quarter is pegged at $11.34 billion, while the same for earnings is pinned at 83 cents per share.See the Zacks Earnings Calendar to stay ahead of market-making news.In the past 60 days, the Zacks Consensus Estimate for Novo Nordisk’s 2024 earnings per share (EPS) declined from $3.28 to $3.16. During the same time frame, the ...